Edition:
India

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

24.23USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$24.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
60,632
52-wk High
$29.97
52-wk Low
$15.37

Select another date:

Thu, Jan 4 2018

BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients

* DECIPHERA PHARMACEUTICALS INITIATES PHASE 3 CLINICAL STUDY WITH DCC-2618 IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (“INVICTUS” STUDY)

BRIEF-Deciphera Pharmaceuticals Announces Orphan Drug Designation From The EMA For DCC-2618 For The Treatment Of Gastrointestinal Stromal Tumors

* DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES ORPHAN DRUG DESIGNATION FROM THE EMA FOR DCC-2618 FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORS Source text for Eikon: Further company coverage:

BRIEF-Deciphera Pharma reports data from ongoing phase 1 clinical study of DCC-2618 

* Deciphera Pharmaceuticals reports data from ongoing phase 1 clinical study of DCC-2618 at the 22nd annual scientific meeting and education day of the society for neuro-oncology Source text for Eikon: Further company coverage:

BRIEF-Deciphera Pharmaceuticals Q3 loss $5.85 per share​

* Deciphera Pharmaceuticals Inc announces third quarter 2017 financial results and corporate highlights

Select another date: